American Heart Journal
Volume 160, Issue 2 , Page e9 , August 2010

Effectiveness and safety of drug-eluting stents in vein grafts: A meta-analysis

References 

  1. Joyal D, Filion KB, Eisenberg MJ. Effectiveness and safety of drug-eluting stents in vein grafts: A meta-analysis. Am Heart J. 2010;159:159–169.e4
  2. Brodie BR, Wilson H, Stuckey T, et al. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. JACC Cardiovasc Interv. 2009;2:1105–1112
  3. Goswami NJ, Gaffigan M, Berrio G, et al. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie “Real World” Stent Registry. Catheter Cardiovasc Interv. 2010;75:93–100
  4. Shishehbor MH, Hawi R, Singh IM, et al. Drug eluting versus bare-metal stents for treating saphenous vein grafts. Am Heart J. 2009;158:637–643
  5. Navarese EP, Lupi A, Buffon A, et al. Meta-analysis of non-randomized studies in interventional cardiology: a critical appraisal. Ital J Pub Health. 2009;6:
  6. In:  Higgins JPT,  Green S editor. Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008]. The Cochrane Collaboration; 2008;Available at: www.cochrane-handbook.org
  7. Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet. 1991;337:867–872

PII: S0002-8703(10)00433-3

doi: 10.1016/j.ahj.2010.05.027

American Heart Journal
Volume 160, Issue 2 , Page e9 , August 2010